sofidexFor patientsAre you a clinician? Clinical site

Health Library  ›  Conditions  ›  Basal ganglia dysfunction

Condition

Basal ganglia dysfunction

Learn how basal ganglia dysfunction can affect movement, behavior, and thinking, including possible causes, diagnosis, treatment, and warning signs.

About 9 minutes to readConditionLast reviewed March 2025

PDF
What it is
Dysfunction of deep-brain movement-control circuits
Body system
Nervous system
Main symptoms
Slowness, stiffness, involuntary movements, balance problems
What causes it
Degenerative, inherited, vascular, medication-related
How it is diagnosed
Neurological examination and cause-specific testing
Main treatment
Cause-directed treatment, symptom medicines, rehabilitation
Can it be cured?
Sometimes — underlying causes can be treated
Is it an emergency?
Sometimes — sudden weakness or speech trouble
Long-term outlook
May improve, remain stable, or progressively worsen

Overview

The basal ganglia are a group of structures deep inside the brain. They help start and control movement, adjust posture, and make movements smooth and purposeful. They also take part in learning, habits, motivation, and emotional responses.

“Basal ganglia dysfunction” means these brain circuits are not working as expected. It is a broad description rather than one specific diagnosis. The pattern can occur in several conditions, including Parkinson’s disease, Huntington’s disease, dystonia, tic disorders, stroke, and certain medication-related movement disorders.

Symptoms depend on which parts of the circuits are affected. Some people have too little movement, such as slowness and stiffness. Others develop extra or involuntary movements, such as twisting, jerking, or repetitive movements. A person may have a mixture of symptoms.

Basal ganglia dysfunction matters because movement problems can affect walking, speaking, swallowing, work, and daily activities. Some underlying conditions can also affect mood, sleep, memory, or behavior. Identifying the cause helps guide treatment and shows whether symptoms are likely to remain stable, improve, or change over time.

Symptoms

Symptoms may begin gradually or appear suddenly, depending on the cause. They may affect one side of the body first or involve both sides.

Movement symptoms can include:

  • Bradykinesia: movements that become unusually slow or small.
  • Rigidity: muscle stiffness that may make movement uncomfortable or difficult.
  • Tremor: rhythmic shaking, often involving the hands, arms, legs, jaw, or head.
  • Dystonia: sustained or repeated muscle contractions that cause twisting, abnormal postures, or painful cramping.
  • Chorea: brief, irregular movements that seem to flow from one body part to another.
  • Athetosis: slower, writhing movements, often involving the hands or feet.
  • Tics: repeated movements or sounds that may be briefly suppressible.
  • Myoclonus: sudden, shock-like muscle jerks.
  • Balance or walking problems: shuffling, freezing in place, reduced arm swing, or repeated falls.
  • Changes in speech or swallowing: soft speech, unclear words, drooling, coughing during meals, or food feeling stuck.

Not everyone has all of these symptoms. Tremor, for example, has many possible causes and does not automatically mean that the basal ganglia are affected.

Some conditions involving basal ganglia circuits can also cause nonmovement symptoms. These may include reduced motivation, depression, anxiety, irritability, impulsive behavior, sleep changes, or problems with attention and planning. Such symptoms can also result from medication effects, stress, or a separate health condition, so they need individual assessment.

The timing of symptoms provides useful clues. A gradual change over months or years may suggest a degenerative or inherited condition. Symptoms that begin within minutes may be related to a stroke or another acute brain problem.

Causes and risk factors

Basal ganglia dysfunction can result from several different processes.

Neurodegenerative conditions damage brain cells over time. Parkinson’s disease involves loss of nerve cells that make dopamine, a chemical used by movement-control circuits. Huntington’s disease is an inherited condition that progressively affects movement, thinking, and behavior. Other less common degenerative disorders can also involve the basal ganglia.

Genetic conditions may cause dystonia, chorea, abnormal iron or copper buildup, or other movement disorders. Some appear in childhood, while others do not become noticeable until adulthood. Having a relative with a movement disorder may increase concern for an inherited cause, but many affected people have no known family history.

Stroke or bleeding in the brain can injure basal ganglia structures. Symptoms often begin suddenly and may include weakness, numbness, speech difficulty, abnormal movement, or reduced alertness. Small strokes can sometimes cause isolated movement symptoms.

Medicines and substances can alter dopamine signaling. Antipsychotic medicines and some medicines used for nausea can cause stiffness, restlessness, tremor, or involuntary facial and body movements. Levodopa and other treatments for Parkinson’s disease may produce involuntary movements after long-term use. Carbon monoxide, methanol, and certain other toxins can also damage these brain regions.

Do not stop a prescribed medicine without medical advice. Abrupt changes can worsen symptoms or cause serious reactions.

Other possible causes include:

  • Head injury or lack of oxygen to the brain
  • Brain tumors or other structural abnormalities
  • Infections or immune-system inflammation affecting the brain
  • Problems with blood sugar, electrolytes, thyroid function, liver function, or kidney function
  • Wilson disease, in which copper builds up in the body
  • Complications around birth that injure movement-control areas of the brain

Risk factors depend on the underlying condition. They may include older age, family history, vascular risks such as high blood pressure and diabetes, exposure to certain medicines or toxins, or a history of brain injury.

Diagnosis

There is no single test for basal ganglia dysfunction. Diagnosis begins with a detailed history and neurological examination.

A clinician may ask when symptoms started, whether they are constant or intermittent, and what makes them better or worse. They will usually review all prescription medicines, over-the-counter products, supplements, and substance exposures. Videos recorded at home can be helpful when abnormal movements come and go.

During the examination, the clinician may assess:

  • Muscle tone, strength, reflexes, and coordination
  • Tremor or other involuntary movements
  • Walking, balance, posture, and arm swing
  • Speed and size of hand or foot movements
  • Eye movements, facial expression, speech, and swallowing
  • Memory, attention, mood, and behavior when relevant

Blood tests may look for treatable causes, such as thyroid disease, abnormal blood sugar, liver or kidney problems, infection, or changes in copper metabolism. The tests selected depend on the person’s age, symptoms, medical history, and examination.

Magnetic resonance imaging, or MRI, can show strokes, tumors, injury, inflammation, and some patterns associated with degenerative or metabolic disorders. A computed tomography, or CT, scan is often used when symptoms begin suddenly or when bleeding is a concern.

Specialized imaging that evaluates dopamine-related activity may occasionally help distinguish certain parkinsonian conditions from disorders such as essential tremor. It does not identify every cause and cannot replace a clinical examination.

Genetic counseling and testing may be considered when symptoms or family history suggest an inherited disorder. Counseling before testing is important because results can have emotional, medical, employment, insurance, and family implications. In some cases, spinal fluid testing, electrical studies, or evaluation by a movement-disorders neurologist may be needed.

Treatment and management

Treatment depends on the cause, the type of movement problem, and how symptoms affect daily life. Because basal ganglia dysfunction is not one disease, no single treatment works for everyone.

When possible, clinicians treat the underlying cause. This may involve managing a stroke, correcting a metabolic problem, treating inflammation or infection, reducing exposure to a toxin, or carefully changing a medicine that may be contributing. Medication changes should be supervised by the prescribing clinician.

Medicines may help regulate movement or related symptoms. Dopamine-replacing or dopamine-mimicking treatments can improve slowness and stiffness in some parkinsonian disorders. Other medicines may be used for dystonia, chorea, tics, tremor, muscle jerks, mood symptoms, or sleep problems. The benefits differ by condition, and some medicines can worsen another type of movement.

Botulinum toxin injections may help when dystonia or another muscle overactivity problem is limited to particular areas, such as the neck, eyelids, jaw, arm, or foot. The injections temporarily reduce excessive signaling to selected muscles and are usually repeated at planned intervals.

Rehabilitation is often an important part of care:

  • Physical therapy can address strength, flexibility, walking, balance, and fall prevention.
  • Occupational therapy can suggest safer ways to dress, bathe, cook, work, and use adaptive equipment.
  • Speech-language therapy can help with speech volume, communication, drooling, and swallowing.
  • Nutrition support may be useful if swallowing difficulty, weight loss, constipation, or medication timing affects eating.

Regular physical activity may help preserve mobility, balance, and general health. The safest type and intensity depend on symptoms, fall risk, and other medical conditions.

Deep brain stimulation is a surgical treatment in which thin electrodes are placed in specific brain areas. Electrical signals help regulate abnormal movement circuits. It may reduce symptoms in carefully selected people with Parkinson’s disease, dystonia, or essential tremor. It does not cure the underlying disorder, and evaluation by a specialist team is required.

Support for mental health, sleep, caregiving, driving, school, or employment may also be part of management. Treatment plans often need adjustment as symptoms and personal goals change.

Complications

Possible complications depend on the severity and cause of the dysfunction. Walking and balance problems can lead to falls, injuries, and reduced independence. Stiffness or limited movement may contribute to pain, constipation, skin problems, blood clots, or loss of physical conditioning.

Swallowing difficulty can cause weight loss, dehydration, or aspiration, which means food or liquid enters the airway. Aspiration can lead to pneumonia. A swallowing assessment can identify safer food textures, positions, or techniques.

Changes in mood, thinking, judgment, or impulse control can affect relationships and financial safety. These symptoms deserve medical attention and should not be treated as personal failings.

Treatments can also cause complications. Examples include sleepiness, low blood pressure, confusion, hallucinations, restlessness, or new involuntary movements. Side effects should be discussed with the treating clinician rather than managed by abruptly stopping medicine.

Follow up

Routine follow-up is used to track symptoms, daily function, treatment benefits, and side effects. The clinician may also review falls, swallowing, sleep, mood, driving, work, and caregiver needs. Keeping a symptom diary can help show how movements relate to medicine timing, meals, stress, or sleep.

Contact a clinician promptly if symptoms are worsening, falls are becoming more frequent, swallowing is difficult, weight is falling without explanation, or a new movement begins after a medicine change. New confusion, hallucinations, severe depression, or unsafe impulsive behavior also deserves timely assessment.

Seek emergency care for:

  • Sudden facial drooping, weakness, numbness, loss of balance, vision change, or trouble speaking
  • A sudden severe headache with neurological symptoms
  • Choking, inability to breathe, or inability to swallow saliva
  • New abnormal movements with loss of consciousness or ongoing seizure activity
  • High fever, marked stiffness, confusion, or reduced alertness, especially after a medicine change
  • Thoughts of suicide or an immediate risk of harm

These symptoms may have causes other than basal ganglia dysfunction, but they require urgent evaluation.

Go through these one question at a time →

Sources

  1. 1National Institute of Neurological Disorders and Stroke. “Parkinson’s Disease.” National Institutes of Health.
  2. 2National Institute of Neurological Disorders and Stroke. “Huntington’s Disease.” National Institutes of Health.
  3. 3Bloem BR, Okun MS, Klein C. Parkinson’s disease. The Lancet. 2021;397(10291):2284-2303. doi:10.1016/S0140-6736(21)00218-X.
  4. 4Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nature Reviews Disease Primers. 2018;4(1):25. doi:10.1038/s41572-018-0023-6.
  5. 5McColgan P, Tabrizi SJ. Huntington’s disease: a clinical review. European Journal of Neurology. 2018;25(1):24-34. doi:10.1111/ene.13413.
  6. 6Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548-560. doi:10.1001/jama.2019.22360.
  7. 7American College of Radiology. ACR Appropriateness Criteria: Movement Disorders and Neurodegenerative Diseases. Revised 2022.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Basal ganglia dysfunction; [reviewed 2025 Mar 1; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/conditions/basal-ganglia-dysfunction

APA 7th

sofidex. (2025, March 1). Basal ganglia dysfunction. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/conditions/basal-ganglia-dysfunction

AMA 11th

Basal ganglia dysfunction. sofidex. Reviewed March 1, 2025. Accessed November 10, 2026. https://sofidex.com/patients/conditions/basal-ganglia-dysfunction

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.